150 related articles for article (PubMed ID: 1003541)
41. Leukocyte migration inhibition responses to MCF-7, murine mammary tumor virus, and Thomsen-Friedenreich antigen in a series of cancer patients.
Bernhard MI; Wanebo HJ; Helm J; Pace RC; Kaiser DL
Cancer Res; 1983 Apr; 43(4):1932-7. PubMed ID: 6299532
[No Abstract] [Full Text] [Related]
42. Leucocyte adherence inhibition test for the detection of cell-mediated immunity to malignant melanoma.
Winter M; Nelson DS; Milton GW
Aust N Z J Med; 1980 Aug; 10(4):405-9. PubMed ID: 7000060
[TBL] [Abstract][Full Text] [Related]
43. Humoral antitumor immune responses in patients with breast cancer measured with the leukocyte adherence inhibition technique.
Kotlar HK; Sanner T
J Natl Cancer Inst; 1981 Feb; 66(2):265-71. PubMed ID: 7005505
[TBL] [Abstract][Full Text] [Related]
44. [Leukocyte migration inhibition and leukocyte adherence inhibition (LMI- and LAI-assay) in cancer patients by using preparations from human fetuses].
Albrecht S; Thuy LT; Pasternak G; Schlott B; Reinhöfer J; Lunow E; Loewe G; Gütz HJ
Acta Biol Med Ger; 1978; 37(11-12):1747-57. PubMed ID: 382722
[TBL] [Abstract][Full Text] [Related]
45. Leukocyte migration studies in gastric cancer detection: an approach toward improved specificity and sensitivity.
Zöller M; Matzku S; Schulz U
J Natl Cancer Inst; 1977 Apr; 58(4):897-904. PubMed ID: 845993
[TBL] [Abstract][Full Text] [Related]
46. Leukocyte migration inhibition by cancer patients' sera.
Cochran AJ; Mackie RM; Ross CE; Ogg LJ; Jackson AM
Int J Cancer; 1976 Sep; 18(3):274-81. PubMed ID: 1066319
[TBL] [Abstract][Full Text] [Related]
47. Sensitization of leukocytes of cancer patients against fetal antigens: leukocyte migration studies.
Zöller M; Matzku S; Schulz U; Price MR
J Natl Cancer Inst; 1979 Aug; 63(2):285-93. PubMed ID: 88534
[TBL] [Abstract][Full Text] [Related]
48. Indirect leukocyte migration inhibition in breast cancer and benign breast disease patients by mouse mammary tumor virus grown in feline kidney cells.
McCoy JL; Tagliabue A; Ames RE; Teramoto YA; Cannon GB; Alford C; Herberman RB; Schlom J
J Natl Cancer Inst; 1984 Mar; 72(3):569-76. PubMed ID: 6321840
[TBL] [Abstract][Full Text] [Related]
49. Indirect leukocyte migration inhibition reactions to a 3-M KCl extract of lung adenocarcinoma by lung cancer patients.
Suslov I; McCoy JL; Herberman RB
J Natl Cancer Inst; 1981 Feb; 66(2):233-7. PubMed ID: 7005504
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of human leukocyte migration in agarose by KC1 extracts of lung cancer.
Boddie AW; Holmes EC; Roth JA
Surg Forum; 1974; 25(0):109-10. PubMed ID: 4439134
[No Abstract] [Full Text] [Related]
51. Leukocyte migration inhibition response to various antigen preparations of autologous and homologous breast cancer in patients with primary breast cancer.
Fukuda M; Wanebo HJ; Tsuei L; Sarkar NH
J Natl Cancer Inst; 1979 Nov; 63(5):1161-9. PubMed ID: 91696
[No Abstract] [Full Text] [Related]
52. Cell-mediated immunity to melanoma-associated antigens in patients with ocular malignant melanoma.
Char DH; Jerome L; McCoy JL; Herberman RB
Am J Ophthalmol; 1975 May; 79(5):812-6. PubMed ID: 1146943
[TBL] [Abstract][Full Text] [Related]
53. Peripheral leukocyte migration inhibition reactivity to breast cancer antigens in patients with breast cancer and in normal controls.
Brandes LJ; Goldenberg GJ
Cancer Res; 1976 Oct; 36(10):3707-10. PubMed ID: 953996
[TBL] [Abstract][Full Text] [Related]
54. The LMI test in colon, breast and lung cancer long survivors.
Fazio M; Calabrese F; Coluccia C; Giacomasso S; Casadio C; Mancuso M; Negri L; Mastromatteo V
Panminerva Med; 1992; 34(2):60-4. PubMed ID: 1408329
[TBL] [Abstract][Full Text] [Related]
55. In vitro cellular immunity in mammary carcinoma.
Jones BM; Turnbull AR
Br J Cancer; 1974 Apr; 29(4):337-9. PubMed ID: 4852381
[No Abstract] [Full Text] [Related]
56. Antigen-reactive cells to tumor antigens in normal and tumor patients.
Falk RE; MacGregor AB
J Surg Res; 1976 Mar; 20(3):247-53. PubMed ID: 772313
[No Abstract] [Full Text] [Related]
57. Inhibition of human leukocyte migration in agar by 3-M potassium chloride extracts of stomach, colon, and lung cancers.
Iwaki J; Akagi M; Sairenji T; Hinuma Y
J Natl Cancer Inst; 1979 Jul; 63(1):5-10. PubMed ID: 286834
[TBL] [Abstract][Full Text] [Related]
58. High incidence of migration inhibition reactivity to lung tumor-associated antigen by normal donors in close contact with lung cancer patients or materials.
Suslov IM; McCoy JL; Cannon GB; Herberman RB
J Natl Cancer Inst; 1980 Oct; 65(4):709-13. PubMed ID: 6932522
[TBL] [Abstract][Full Text] [Related]
59. Sensitization to tumour-associated antigens in human breast carcinoma.
Cochran AJ; Grant RM; Spilg WG; Mackie RM; Ross CE; Hoyle DE; Russell JM
Int J Cancer; 1974 Jul; 14(1):19-25. PubMed ID: 4617707
[No Abstract] [Full Text] [Related]
60. Lack of leukocyte migration inhibition by hepatitis B surface antigen in hepatocellular carcinoma patients.
Lee CS; Chang KJ; Chen DS; Lin TY
Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1979 Sep; 12(3):86-92. PubMed ID: 94850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
